update
US FDA warns Lonza about Walkersville site
The US FDA has warned Lonza about operations at its facility in Walkersville, Maryland, raising concerns about validation and aseptic process simulations.
Archives for April 24, 2017
Fresenius Kabi to buy Merck KGaA biosimilar candidates
Fresenius Kabi has announced plans to purchase Merck KGaA’s biosimilars business.
DISPATCHES FROM BPI EUROPE 2017
Getting a feel for biomanufacturing at the Biotech Training Facility
Hands-on teaching offers drugmakers, vendors and regulators a better understanding of bioprocessing, according to the managing director of a training facility in Leiden, The Netherlands.
Filtration is a ‘high value process at a marginal cost,’ says Danaher
Danaher reported mid-single-digit growth from its bioprocessing subsidiary Pall Life Science and expects a continued trajectory to support Biopharma’s filtration needs.